Mismatch Repair Deficiency Testing for Immune Checkpoint Blockade Therapy: Immunohistochemistry vs Microsatellite Instability
Literature
Read More
Identifying New Biomarkers and Targeted Molecules for Immunotherapy Using Targeted RNA Next Generation Sequencing
Literature
Read More
NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018
Press Release
Read More
Efficient Large Scale Cell Classification and Analysis for MultiOmyx™ Assays: A Deep Learning Approach
Literature
Read More
Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
Literature
Read More
Tumor-Infiltrating Myeloid Cells – Using MultiOmyx™ to Distinguish between TAMs, TANs, and MDSCs in the Pancreatic Tumor Microenvironment
Literature
Read More